Michael Kutryk


Scientist, Keenan Research Centre for Biomedical Science

Recent Publications

  1. McKavanagh, P, Zawadowski, G, Ahmed, N, Kutryk, M. The evolution of coronary stents. Expert Rev Cardiovasc Ther. 2018;16 (3):219-228. doi: 10.1080/14779072.2018.1435274. PubMed PMID:29381087 .
  2. Gu, X, Zhang, Q, Sun, H, Fei, J, Zhang, X, Kutryk, MJ et al.. Transcatheter Closure Versus Repeat Surgery for the Treatment of Postoperative Left-to-Right Shunts: A Single Center 15-Year Experience. Cardiol Res. 2017;8 (6):286-292. doi: 10.14740/cr629e. PubMed PMID:29317971 PubMed Central PMC5755660.
  3. Gu, X, Zhang, Q, Sun, H, Fei, J, Zhang, X, Kutryk, MJ et al.. Transcatheter closure of calcified patent ductus arteriosus in older adult patients: Immediate and 12-month follow-up results. Congenit Heart Dis. 2017;12 (3):289-293. doi: 10.1111/chd.12437. PubMed PMID:27874259 .
  4. Stone, GW, Sabik, JF, Serruys, PW, Simonton, CA, Généreux, P, Puskas, J et al.. Everolimus-Eluting Stents or Bypass Surgery for Left Main Coronary Artery Disease. N. Engl. J. Med. 2016;375 (23):2223-2235. doi: 10.1056/NEJMoa1610227. PubMed PMID:27797291 .
  5. Ting, R, Tejpal, A, Finken, L, Fisher, M, Lefkowitz, C, Parthasarathy, H et al.. Repatriation to referral hospital after reperfusion of STEMI patients transferred for primary percutaneous coronary intervention: Insights of a Canadian regional STEMI care system. Am. Heart J. 2016;177 :145-52. doi: 10.1016/j.ahj.2016.04.017. PubMed PMID:27297860 .
  6. Lu, J, Bagai, A, Buller, C, Cheema, A, Graham, J, Kutryk, M et al.. Incidence and characteristics of inappropriate and false-positive cardiac catheterization laboratory activations in a regional primary percutaneous coronary intervention program. Am. Heart J. 2016;173 :126-33. doi: 10.1016/j.ahj.2015.10.027. PubMed PMID:26920605 .
  7. Mukovozov, I, Huang, YW, Zhang, Q, Liu, GY, Siu, A, Sokolskyy, Y et al.. The Neurorepellent Slit2 Inhibits Postadhesion Stabilization of Monocytes Tethered to Vascular Endothelial Cells. J. Immunol. 2015;195 (7):3334-44. doi: 10.4049/jimmunol.1500640. PubMed PMID:26297762 .
  8. Granton, J, Langleben, D, Kutryk, MB, Camack, N, Galipeau, J, Courtman, DW et al.. Endothelial NO-Synthase Gene-Enhanced Progenitor Cell Therapy for Pulmonary Arterial Hypertension: The PHACeT Trial. Circ. Res. 2015;117 (7):645-54. doi: 10.1161/CIRCRESAHA.114.305951. PubMed PMID:26195220 .
  9. Li, J, Zhang, Q, Li, D, An, Y, Kutryk, MB. Hydroxybutyl Chitosan Polymer-Mediated CD133 Antibody Coating of Metallic Stents to Reduce Restenosis in a Porcine Model of Atherosclerosis. J. Cardiovasc. Pharmacol. Ther. 2015;20 (3):322-9. doi: 10.1177/1074248414558518. PubMed PMID:25412893 .
  10. Mrówczyński, W, Rungatscher, A, Buchegger, F, Tille, JC, Namy, S, Ratib, O et al.. Biological effects of anti-CD34-coated ePTFE vascular grafts. Early in vivo experimental results. Kardiochir Torakochirurgia Pol. 2014;11 (2):182-90. doi: 10.5114/kitp.2014.43848. PubMed PMID:26335112 PubMed Central PMC4283864.
Search PubMed

Affiliations & Other Activities

  • Scientist, Li Ka Shing Knowledge Institute, St. Michael’s Hospital
  • Staff Physician, St. Michael’s Hospital
  • Assistant Professor, University of Toronto